QIAGEN N.V. Cash And Cash Equivalents At Carrying Value

• QIAGEN N.V. showed an increase of +26.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from QIAGEN N.V.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2007 to 2025), QIAGEN N.V.'s Cash And Cash Equivalents At Carrying Value has grown by 141.6%.
• Historical annual values: Fiscal year 2025: $839.01 million | Fiscal year 2024: $663.56 million | Fiscal year 2023: $668.08 million | Fiscal year 2022: $730.67 million | Fiscal year 2021: $880.52 million | Fiscal year 2020: $597.98 million | Fiscal year 2019: $623.65 million | Fiscal year 2018: $1.16 billion | Fiscal year 2017: $657.71 million | Fiscal year 2016: $439.18 million | Fiscal year 2015: $290.01 million | Fiscal year 2014: $392.67 million | Fiscal year 2013: $330.30 million | Fiscal year 2012: $394.04 million | Fiscal year 2011: $221.13 million | Fiscal year 2010: $828.41 million | Fiscal year 2009: $825.56 million | Fiscal year 2008: $333.31 million | Fiscal year 2007: $347.32 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026